Wexford Capital’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Wexford Capital’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-13,984	Closed	-$627K	–	235
2021 Q1	$627K	Hold	13,984	–	–	0.09%	124
2020 Q4	$798K	Sell	13,984 -5,816	-29%	-$345K	0.13%	116
2020 Q3	$1.02M	Buy	+19,800	New	+$970K	0.27%	73
2020 Q2	–	Sell	-10,007	Closed	-$412K	–	229
2020 Q1	$412K	Buy	10,007 +5,007	+100%	+$278K	0.15%	69
2019 Q4	$311K	Buy	+5,000	New	+$238K	0.05%	109

Other funds holding DCPH

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wexford Capital's DCPH Position: Q2 2021 in Review

Wexford Capital sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2021, closing a stake of 13,984 shares — an estimated $627K sold.

Wexford Capital first reported a position in DCPH in Q4 2019 and held it in 5 quarters. The position peaked at $1.02M in Q3 2020. 147 funds tracked by Wall St. Rank hold DCPH as of Q2 2021.

Wexford Capital reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Wexford Capital sold 13,984 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $627K.
Wexford Capital first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
Wexford Capital's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.02M in Q3 2020.
147 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Wexford Capital's 13F filing for Q2 2021, filed 16 Aug 2021.